Deutsche Bank Ag\ Regenxbio Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Regenxbio Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 184,653 shares of RGNX stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,653

Previous 157,974 16.89%

Holding current value

$1.41 Million

Previous $1.85 Million 4.82%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.49 - $14.39 $279,862 - $383,910	26,679 Added 16.89%	184,653 $1.94 Million
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $2,359 - $4,413	-205 Reduced 0.13%	157,974 $1.85 Million
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $1.7 Million - $3.45 Million	140,025 Added 771.32%	158,179 $3.33 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $5,014 - $8,098	389 Added 2.19%	18,154 $325,000
Q3 2023 Nov 09, 2023	BUY	$16.46 - $19.99 $46,532 - $56,511	2,827 Added 18.92%	17,765 $292,000
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $232,329 - $292,737	-13,484 Reduced 47.44%	14,938 $298,000
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $19,164 - $26,023	-1,060 Reduced 3.6%	28,422 $537,000
Q4 2022 Feb 13, 2023	BUY	$20.4 - $24.73 $92,901 - $112,620	4,554 Added 18.27%	29,482 $668,000
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $52,671 - $82,799	-2,363 Reduced 8.66%	24,928 $658,000
Q2 2022 Aug 11, 2022	SELL	$19.35 - $35.04 $96,498 - $174,744	-4,987 Reduced 15.45%	27,291 $675,000
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $11,005 - $15,336	447 Added 1.4%	32,278 $1.07 Million
Q4 2021 Feb 11, 2022	SELL	$30.19 - $40.28 $1.04 Million - $1.39 Million	-34,565 Reduced 52.06%	31,831 $1.04 Million
Q3 2021 Nov 04, 2021	SELL	$29.09 - $45.68 $19,723 - $30,971	-678 Reduced 1.01%	66,396 $2.78 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $40.48 $145,453 - $181,390	-4,481 Reduced 6.26%	67,074 $2.61 Million
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $256,377 - $381,018	7,628 Added 11.93%	71,555 $2.44 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $199,616 - $371,457	7,527 Added 13.35%	63,927 $2.9 Million
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $1.08 Million - $1.6 Million	-39,855 Reduced 41.41%	56,400 $1.55 Million
Q2 2020 Aug 13, 2020	BUY	$27.75 - $43.44 $446,358 - $698,732	16,085 Added 20.06%	96,255 $3.54 Million
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $325,918 - $821,617	-15,159 Reduced 15.9%	80,170 $2.6 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $1.67 Million - $2.17 Million	48,387 Added 103.08%	95,329 $3.9 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $45,435 - $72,605	-1,427 Reduced 2.95%	46,942 $1.67 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $10.7 Million - $15.1 Million	-254,157 Reduced 84.01%	48,369 $2.48 Million
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $5.18 Million - $7.92 Million	-126,845 Reduced 29.54%	302,526 $17.3 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $2.87 Million - $5.52 Million	73,397 Added 20.62%	429,371 $18 Million
Q3 2018 Dec 21, 2021	BUY	$65.0 - $82.15 $5.68 Million - $7.18 Million	87,404 Added 32.54%	355,974 $26.9 Million
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $1.59 Million - $2.01 Million	24,439 Added 10.01%	268,570 $20.3 Million
Q2 2018 Apr 21, 2020	BUY	$27.2 - $74.35 $1.62 Million - $4.44 Million	59,719 Added 32.38%	244,131 $17.5 Million
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $4.33 Million - $11.8 Million	-159,341 Reduced 46.35%	184,412 $13.2 Million
Q1 2018 Oct 18, 2019	BUY	$24.05 - $37.5 $1.09 Million - $1.7 Million	45,251 Added 15.16%	343,753 $10.3 Million
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $2.81 Million - $4.38 Million	116,862 Added 64.34%	298,502 $8.91 Million
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $320,710 - $426,791	-12,335 Reduced 6.36%	181,640 $6.04 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $3.49 Million - $6.39 Million	193,975	193,975 $6.39 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account